ATS 2018 International Conference - Mobile

Peter Howarth

Making the Switch to Mepolizumab in Patients with Severe Eosinophilic Asthma

Global Respiratory Franchise, GlaxoSmithKline, London, UK

Session(s)

Nucala▼(Mepolizumab): Treating Severe Eosinophilic Asthma Patients With Overlapping Phenot...
Tuesday, May 22 11:30 AM - 12:15 PM